Cover
Cover - shares | 3 Months Ended | |
Nov. 30, 2021 | Jan. 13, 2022 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Document Period End Date | Nov. 30, 2021 | |
Document Fiscal Period Focus | Q1 | |
Document Fiscal Year Focus | 2022 | |
Current Fiscal Year End Date | --08-31 | |
Entity File Number | 333-228161 | |
Entity Registrant Name | UNEX HOLDINGS INC. | |
Entity Central Index Key | 0001700844 | |
Entity Tax Identification Number | 98-1353613 | |
Entity Incorporation, State or Country Code | NV | |
Entity Address, Address Line One | 31-A2, Jalan 5/32A | |
Entity Address, Address Line Two | 6 ½ Miles off | |
Entity Address, City or Town | Jalan Kepong | |
Entity Address, Country | MY | |
Entity Address, Postal Zip Code | 52000 | |
City Area Code | 603 | |
Local Phone Number | 6243 3379 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Elected Not To Use the Extended Transition Period | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 2,970,000 |
Condensed Balance Sheets (Unaud
Condensed Balance Sheets (Unaudited) - USD ($) | Nov. 30, 2021 | Aug. 31, 2021 |
Current Assets | ||
Cash | ||
Total Current Assets | ||
Non- Current assets | ||
Total Non-Current Assets | ||
Total Assets | ||
Current Liabilities | ||
Accrued expenses | 12,000 | 9,500 |
Amount owing to Related Company | 45,134 | 44,134 |
Total Current Liabilities | 57,134 | 53,634 |
Total Liabilities | 57,134 | 53,634 |
Stockholders’ Equity (Deficit) | ||
Common stock, $0.001 par value, 75,000,000 share authorized; 2,970,000 share issued and outstanding | 2,970 | 2,970 |
Additional paid-in-capital | 36,022 | 36,022 |
Accumulated deficit | (96,126) | (92,626) |
Total Stockholders’ Equity (Deficit) | (57,134) | (53,634) |
Total Liabilities and Stockholders’ Equity (Deficit) |
Condensed Balance Sheets (Una_2
Condensed Balance Sheets (Unaudited) (Parenthetical) - $ / shares | Nov. 30, 2021 | Aug. 31, 2021 |
Statement of Financial Position [Abstract] | ||
Common stock, par value | $ 0.001 | $ 0.001 |
Common stock, shares authorized | 75,000,000 | 75,000,000 |
Common stock, shares issued | 2,970,000 | 2,970,000 |
Common stock, shares outstanding | 2,970,000 | 2,970,000 |
Condensed Statements of Operati
Condensed Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | |
Nov. 30, 2021 | Nov. 30, 2020 | |
Operating expenses | ||
General and administrative expenses | $ 3,500 | $ 5,773 |
(Loss) before provision for the income taxes | (3,500) | (5,773) |
Provision for income taxes | ||
Net (Loss) | $ (3,500) | $ (5,773) |
Loss per common share: | ||
Basic and Diluted | $ 0 | $ 0 |
Weighted Average Number of common Share Outstanding : | ||
Basic and Diluted | 2,970,000 | 2,970,000 |
Condensed Statement of Changes
Condensed Statement of Changes In Equity (Deficit) (Unaudited) - USD ($) | Common Stock [Member] | Additional Paid-in Capital [Member] | Retained Earnings [Member] | Total |
Beginning balance, value at Aug. 31, 2020 | $ 2,970 | $ 22,730 | $ (31,081) | $ (5,381) |
Balance, shares at Aug. 31, 2020 | 2,970,000 | |||
Net (loss) | (5,773) | (5,773) | ||
Ending balance, value at Nov. 30, 2020 | $ 2,970 | 22,730 | (36,854) | (11,154) |
Balance, shares at Nov. 30, 2020 | 2,970,000 | |||
Beginning balance, value at Aug. 31, 2021 | $ 2,970 | 36,022 | (92,626) | (53,634) |
Balance, shares at Aug. 31, 2021 | 2,970,000 | |||
Net (loss) | (3,500) | (3,500) | ||
Ending balance, value at Nov. 30, 2021 | $ 2,970 | $ 36,022 | $ (96,126) | $ (57,134) |
Balance, shares at Nov. 30, 2021 | 2,970,000 |
Condensed Statements of Cash Fl
Condensed Statements of Cash Flows (Unaudited) - USD ($) | 3 Months Ended | |
Nov. 30, 2021 | Nov. 30, 2020 | |
Cash flows from operating activities | ||
Net Loss | $ (3,500) | $ (5,773) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Depreciation expenses | 79 | |
Increase in amount due to related party | 3,500 | (233) |
Net cash used in operating activities | (5,927) | |
Cash flow from investing activities: | ||
Cash flow from financing activities | ||
Proceeds from sale of common stock | 750 | |
Net cash provided financing activities | 750 | |
Net decrease in cash and equivalents | (5,177) | |
Cash at beginning of the period | 5,676 | |
Cash at end of the period | 499 | |
Cash paid for : | ||
Interest | ||
Taxes | ||
Supplemental disclosure of non-cash investing and financing information : | ||
Repurchase of common stock for refund payable | 1,950 | |
Total | $ 1,950 |
ORGANIZATION AND BUSINESS
ORGANIZATION AND BUSINESS | 3 Months Ended |
Nov. 30, 2021 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
ORGANIZATION AND BUSINESS | NOTE 1 – ORGANIZATION AND BUSINESS UNEX HOLDINGS INC. (the “Company” or “Unex”) is a corporation established under the corporation laws in the State of Nevada on February 17, 2017. The Company has adopted August 31 fiscal year end. The Company was formed to provide geodesy services, and we are still in the development stage. Upon completion of the Transactions (defined in Note 7), the Company will be principally involved in the research and development, manufacturing sale and marketing of heating, ventilation and air conditioning (“HVAC”) products. |
GOING CONCERN
GOING CONCERN | 3 Months Ended |
Nov. 30, 2021 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
GOING CONCERN | NOTE 2 – GOING CONCERN The Company’s financial statements as of November 30, 2021, is prepared using generally accepted accounting principles in the United States of America applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern. The Company incurred net loss of $ 3,500 and $ 5,773 for three months ended November 30, 2021 and 2020, respectively. As of November 30, 2021 and August 31, 2021, the Company recorded net current liability of $ 57,134 and $ 53,634 , respectively, and stockholders’ deficit of $ 57,134 and $ 53,634 , respectively. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. With the injection of a viable business into the Company (“New Business”) contemplated under the Transaction (defined in Note 7), the Management believes that the actions to be taken by the new Management to further implement the business plans for the New Business including expansion in product offerings, geographical expansion, generate revenue through expansion of revenue streams and customer base (retail, commercial and industrial as well as private label and licensing clientele), improvement of profitability by achieving economies of scale provide the opportunity for the Company to continue as a going concern. In addition, the Company is also working on raising additional funding to finance the operations as well as business expansion. Our ability to continue as a going concern is dependent upon our capability to further implement our business plan and generate revenues. These financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. |
SUMMARY OF SIGNIFICANT ACCOUNTI
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 3 Months Ended |
Nov. 30, 2021 | |
Accounting Policies [Abstract] | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of presentation The accompanying unaudited condensed financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information, and with the rules and regulations of the United States Securities and Exchange Commission (the “SEC”) set forth in Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited condensed financial statements furnished reflect all adjustments (consisting of normal recurring accruals) which are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented. Unaudited condensed results are not necessarily indicative of the results for the full fiscal year. These financial statements should be read along with the financial statements of the Company for the period ended August 31, 2021 and notes thereto contained in the Company’s Form 10-K. Use of Estimates Preparing financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. Actual results and outcomes may differ from management’s estimates and assumptions. Income Taxes The Company follows the liability method of accounting for income taxes. Under this method, deferred income tax assets and liabilities are recognized for the estimated tax consequences attributable to differences between the financial statement carrying values and their respective income tax basis (temporary differences). A valuation allowance related to a deferred tax asset is recorded when it is more likely than not that some portion of the deferred tax asset will not be realized. The effect on deferred income tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Property and Equipment Depreciation Policy Property and equipment are stated at cost and depreciated on the straight-line method over the estimated life of the asset, which is 3 Recently issued Accounting Pronouncements There were various accounting standards and interpretations issued recently, none of which are expected to a have a material impact on our financial position, operations or cash flows. Fair Value Measurements The Company adopted the provisions of ASC Topic 820, “Fair Value Measurements and Disclosures”, which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair value measurements. The estimated fair value of certain financial instruments, including cash and cash equivalents are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments. ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value: Level 1 — quoted prices in active markets for identical assets or liabilities Level 2 — quoted prices for similar assets and liabilities in active markets or inputs that are observable Level 3 — inputs that are unobservable (for example cash flow modeling inputs based on assumptions) The Company has no assets or liabilities valued at fair value on a recurring basis. |
COMMON STOCK
COMMON STOCK | 3 Months Ended |
Nov. 30, 2021 | |
Equity [Abstract] | |
COMMON STOCK | NOTE 4 – COMMON STOCK On December 16, 2021, the Company has increased the authorized common stock from 75,000,000 shares with a par value of $ 0.001 per share to 1,000,000,000 0.001 As of November 30, 2021 and August 31, 2021, the Company had 2,970,000 |
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS | 3 Months Ended |
Nov. 30, 2021 | |
Related Party Transactions [Abstract] | |
RELATED PARTY TRANSACTIONS | NOTE 5 – RELATED PARTY TRANSACTIONS In support of the Company’s efforts and cash requirements, it may rely on advances from related parties until such time that the Company can support its operations or attains adequate financing through sales of its equity or traditional debt financing. There is no formal written commitment for continued support by officers, directors, or shareholders. Amounts represent advances or amounts paid in satisfaction of liabilities. The advances are considered temporary in nature and have not been formalized by a promissory note. As of November 30, 2021 and August 31, 2021, amount due to a related party amounting $ 45,134 and $ 44,134 respectively, which is mainly an advance from a company related to the Company’s major stockholder, officer and director, Dr. Low Wai Koon (“Dr. Low”) to pay for operating expenses. The amount is non-interest bearing, due upon demand and unsecured. |
CHANGE OF CONTROL
CHANGE OF CONTROL | 3 Months Ended |
Nov. 30, 2021 | |
Change Of Control | |
CHANGE OF CONTROL | NOTE 6 – CHANGE OF CONTROL Pursuant to the terms of the Securities Purchase Agreement dated February 26, 2021, by and among Veniamin Minkov, the former sole officer, director, and majority stockholder of the Company and Dr. Low (the “Unex Agreement”), effective February 26, 2021 (the “Effective Time”), Veniamin Minkov, the then sole executive officer and director of the Company and the owner of 2,000,000 restricted shares of the Company’s common stock representing 67.34% of the Company’s issued and outstanding common stock (“Unex Shares”), sold the Unex Shares to Dr. Low for an aggregate consideration of $ 340,000 , or approximately $ 0.17 per share. In addition, certain stockholders purchased 966,000 shares of the Company’s common stock in a series of private transactions for $ 0.05176 a share from non-affiliates of the Company (the “Non-Affiliate Shares”). Upon completion of the purchase of the Unex Shares, Dr. Low owned 2,000,000 shares, or approximately 67.34% of the issued and outstanding common stock of the Company, which resulted in a change of control of the Company. Upon completion of the Non-Affiliate Shares, certain stockholders owned 966,000 shares or approximately 32.53% of the issued and outstanding common stock of the Company. The balance 4,000 shares are held by public stockholders. In connection with the Unex Agreement, on February 26, 2021, Veniamin Minkov resigned as the President, Treasurer, and Secretary of the Company and Chairman of the Board of the “Company. Mr. Minkov’s resignation as President, Treasurer, and Secretary of the Company and Chairman of the Board is effective immediately. Mr. Minkov’s resignation as a director will become effective ten (10) days following the filing by the Company of the Information Statement on Schedule 14f-1 with the United States Securities and Exchange Commission. Prior to Mr. Minkov’s resignation, he appointed Dr. Low as the Company’s director and Chairman of the Board, Chief Executive Officer, Chief Financial Officer, President, Secretary and Treasurer, of the Company. In accordance with the terms of the Agreement, Veniamin Minkov warranted that on the Effective Date the Company will have no assets and no debt of any kind including no outstanding tax liabilities and that all existing contracts entered into by the Company shall be cancelled without liability. |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 3 Months Ended |
Nov. 30, 2021 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS | NOTE 7 - SUBSEQUENT EVENTS In accordance with FASB ASC 855-10 Subsequent Events, the Company has analyzed its operations subsequent to November 30, 2021 to the date these consolidated financial statements were issued, and has determined that it does not have any material subsequent events to disclose in these consolidated financial statements, except as follows: On December 20, 2021, the Company and Dr. Low entered into a share transfer agreement, dated December 20, 2021 (the “Evoair International Share Transfer Agreement”), pursuant to which Dr. Low agreed to sell all of his ordinary shares of EvoAir International Limited (“EvoAir International”) to the Company for the consideration of US$ 100 . Pursuant to the terms of a share transfer agreement dated December 20, 2021, Dr. Low, the then sole executive officer and director of the Company and the owner of 2,000,000 restricted shares of the Company’s ordinary shares representing approximately 67.34% of the Company’s then issued and outstanding shares, sold his entire shareholding of the Company to WKL Global Limited (“WKL Global”) for an aggregate consideration of $ 100 . The board of directors and majority shareholders of the Company and WKL Global have approved the Share Transfer Agreement and the transactions contemplated thereunder (the “Change of Control Transaction”). Upon completion of the Transaction, WKL Global Limited owned 2,000,000 shares, or approximately 67.34% of the then issued and outstanding ordinary shares of the Company, which resulted in a change of control of the Company. Subsequently, several transactions took place (together, the “Transactions”) whereby the Company issued and allotted in aggregate 98,809,323 101,779,323 (A) On December 20, 2021, Dr. Low and Chan Kok Wei entered into a share transfer agreement with WKL Eco Earth Holdings Pte. Ltd (“WKL Eco Earth Holdings”), pursuant to which Dr. Low and Chan Kok Wei agreed to sell all their ordinary shares of WKL Green Energy Sdn. Bhd (“WKL Green Energy”) to WKL Eco Earth Holdings in consideration for the allotment and issuance to WKL Global Limited and Allegro Investment (BVI) Limited of 24,000 6,000 0.02% 0.01% (B) On December 20, 2021, Dr. Low, Chan Kok Wei, Ong Bee Chen and certain sellers (“WKLEE Sellers”) entered into a share transfer agreement with WKL Eco Earth Holdings, pursuant to which Dr. Low, Chan Kok Wei, Ong Bee Chen and WKLEE Sellers agreed to sell all their ordinary shares of WKL Eco Earth Sdn. Bhd. (“WKL Eco Earth”) to WKL Eco Earth Holdings in consideration for the allotment and issuance to WKL Global Limited, Allegro Investment (BVI) Limited and WKLEE Sellers of 49,320 8,280 14,400 0.05% 0.009% 0.014% (C) On December 20, 2021, Tan Soon Hock, Ivan Oh Joon Wern and certain relevant interest holders (“Relevant Interest Holders”) entered into an investment exchange agreement with WKL Eco Earth Holdings, pursuant to which Tan Soon Hock, Ivan Oh Joon Wern and the Relevant Interest Holders agreed to sell all relevant interests in the WKL Group to WKL Eco Earth Holdings in consideration for the allotment and issuance of 7,037,762 2,520,000 6,001,794 6.91% 2.48% 5.90% (D) On December 20, 2021, Dr. Low entered into two deed of assignments of intellectual properties with WKL Eco Earth Holdings Pte. Ltd., in respect of Dr. Low’s patents relating to eco-friendly air-conditioner condenser (external unit) and the trademarks described in the deed of assignment thereunder, and in respect of Dr. Low’s patents relating to the portable air-conditioner e-Cond EVO TM 63,362,756 14,297,259 5,487,752 62.25% 14.05% 5.39% |
SUMMARY OF SIGNIFICANT ACCOUN_2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 3 Months Ended |
Nov. 30, 2021 | |
Accounting Policies [Abstract] | |
Basis of presentation | Basis of presentation The accompanying unaudited condensed financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information, and with the rules and regulations of the United States Securities and Exchange Commission (the “SEC”) set forth in Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited condensed financial statements furnished reflect all adjustments (consisting of normal recurring accruals) which are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented. Unaudited condensed results are not necessarily indicative of the results for the full fiscal year. These financial statements should be read along with the financial statements of the Company for the period ended August 31, 2021 and notes thereto contained in the Company’s Form 10-K. |
Use of Estimates | Use of Estimates Preparing financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. Actual results and outcomes may differ from management’s estimates and assumptions. |
Income Taxes | Income Taxes The Company follows the liability method of accounting for income taxes. Under this method, deferred income tax assets and liabilities are recognized for the estimated tax consequences attributable to differences between the financial statement carrying values and their respective income tax basis (temporary differences). A valuation allowance related to a deferred tax asset is recorded when it is more likely than not that some portion of the deferred tax asset will not be realized. The effect on deferred income tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. |
Property and Equipment Depreciation Policy | Property and Equipment Depreciation Policy Property and equipment are stated at cost and depreciated on the straight-line method over the estimated life of the asset, which is 3 |
Recently issued Accounting Pronouncements | Recently issued Accounting Pronouncements There were various accounting standards and interpretations issued recently, none of which are expected to a have a material impact on our financial position, operations or cash flows. |
Fair Value Measurements | Fair Value Measurements The Company adopted the provisions of ASC Topic 820, “Fair Value Measurements and Disclosures”, which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair value measurements. The estimated fair value of certain financial instruments, including cash and cash equivalents are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments. ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value: Level 1 — quoted prices in active markets for identical assets or liabilities Level 2 — quoted prices for similar assets and liabilities in active markets or inputs that are observable Level 3 — inputs that are unobservable (for example cash flow modeling inputs based on assumptions) The Company has no assets or liabilities valued at fair value on a recurring basis. |
GOING CONCERN (Details Narrativ
GOING CONCERN (Details Narrative) - USD ($) | 3 Months Ended | |||
Nov. 30, 2021 | Nov. 30, 2020 | Aug. 31, 2021 | Aug. 31, 2020 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||||
Net Income (Loss) Attributable to Parent | $ 3,500 | $ 5,773 | ||
Liabilities, Current | 57,134 | $ 53,634 | ||
Stockholders' Equity Attributable to Parent | $ 57,134 | $ 11,154 | $ 53,634 | $ 5,381 |
SUMMARY OF SIGNIFICANT ACCOUN_3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) | 3 Months Ended |
Nov. 30, 2021 | |
Accounting Policies [Abstract] | |
Property plant and equipment useful life | 3 years |
COMMON STOCK (Details Narrative
COMMON STOCK (Details Narrative) - $ / shares | Dec. 20, 2021 | Dec. 16, 2021 | Nov. 30, 2021 | Aug. 31, 2021 |
Subsequent Event [Line Items] | ||||
Common Stock, Shares Authorized | 75,000,000 | 75,000,000 | ||
Common Stock, Par or Stated Value Per Share | $ 0.001 | $ 0.001 | ||
Common stock, shares issued | 2,970,000 | 2,970,000 | ||
Common stock, shares outstanding | 2,970,000 | 2,970,000 | ||
Subsequent Event [Member] | ||||
Subsequent Event [Line Items] | ||||
Common Stock, Shares Authorized | 1,000,000,000 | |||
Common Stock, Par or Stated Value Per Share | $ 0.001 | |||
Common stock, shares issued | 101,779,323 | |||
Common stock, shares outstanding | 101,779,323 |
RELATED PARTY TRANSACTIONS (Det
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($) | Nov. 30, 2021 | Aug. 31, 2021 |
Related Party Transactions [Abstract] | ||
Due to Related Parties | $ 45,134 | $ 44,134 |
CHANGE OF CONTROL (Details Narr
CHANGE OF CONTROL (Details Narrative) | Feb. 26, 2021USD ($)$ / sharesshares |
Non-Affiliates [Member] | |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |
Equity Method Investment, Ownership Percentage | 32.53% |
Stock Issued During Period, Shares, Issued for Services | 966,000 |
[custom:NumberOfSharesHeldByPublicStockholders] | 4,000 |
Low Wai Koon [Member] | |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |
Equity Method Investment, Ownership Percentage | 67.34% |
Stock Issued During Period, Shares, Issued for Services | 2,000,000 |
Securities Purchase Agreement [Member] | Veniamin Minkov [Member] | Non-Affiliates [Member] | |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |
Shares Issued, Price Per Share | $ / shares | $ 0.05176 |
Stock Issued During Period, Shares, Issued for Services | 966,000 |
Securities Purchase Agreement [Member] | Veniamin Minkov [Member] | Low Wai Koon [Member] | |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |
Stock Issued During Period, Shares, Restricted Stock Award, Gross | 2,000,000 |
Equity Method Investment, Ownership Percentage | 67.34% |
Stock Issued During Period, Value, Restricted Stock Award, Gross | $ | $ 340,000 |
Shares Issued, Price Per Share | $ / shares | $ 0.17 |
SUBSEQUENT EVENTS (Details Narr
SUBSEQUENT EVENTS (Details Narrative) - USD ($) | Dec. 20, 2021 | Nov. 30, 2021 | Aug. 31, 2021 |
Subsequent Event [Line Items] | |||
Common stock, shares, issued | 2,970,000 | 2,970,000 | |
Common stock, shares, outstanding | 2,970,000 | 2,970,000 | |
Subsequent Event [Member] | |||
Subsequent Event [Line Items] | |||
Sale of stock, description of transaction | Subsequently, several transactions took place (together, the “Transactions”) whereby the Company issued and allotted in aggregate 98,809,323 ordinary shares of common stock to certain parties. On completion of the Transactions, the total number of issued and outstanding shares of common stock of the Company were 101,779,323: | ||
Common stock, shares, issued | 101,779,323 | ||
Common stock, shares, outstanding | 101,779,323 | ||
Subsequent Event [Member] | Over-Allotment Option [Member] | |||
Subsequent Event [Line Items] | |||
Number of shares issued | 98,809,323 | ||
Subsequent Event [Member] | WKL Global Limited [Member] | |||
Subsequent Event [Line Items] | |||
Number of stock issued for consideration | 2,000,000 | ||
Percentage of shares transfered as consideration | 67.34% | ||
Stock Issued During Period, Value, New Issues | $ 100 | ||
Subsequent Event [Member] | Dr Low Wai Koon [Member] | |||
Subsequent Event [Line Items] | |||
Number of stock issued for consideration | 2,000,000 | ||
Percentage of shares transfered as consideration | 67.34% | ||
Subsequent Event [Member] | Dr Low Wai Koon [Member] | Share Transfer Agreement [Member] | EvoAir International [Member] | |||
Subsequent Event [Line Items] | |||
Consideration paid for shares transfer | $ 100 | ||
Subsequent Event [Member] | Dr Low And Chan Kok Wei [Member] | Share Transfer Agreement With WKL Eco Earth Holdings [Member] | WKL Global Limited [Member] | |||
Subsequent Event [Line Items] | |||
Number of stock issued for consideration | 24,000 | ||
Percentage of shares transfered as consideration | 0.02% | ||
Subsequent Event [Member] | Dr Low And Chan Kok Wei [Member] | Share Transfer Agreement With WKL Eco Earth Holdings [Member] | Allegro Investment BVI Limited [Member] | |||
Subsequent Event [Line Items] | |||
Number of stock issued for consideration | 6,000 | ||
Percentage of shares transfered as consideration | 0.01% | ||
Subsequent Event [Member] | Dr. Low, Chan Kok Wei, Ong Bee Chen [Member] | Share Transfer Agreement With WKL Eco Earth Holdings [Member] | WKL Global Limited [Member] | |||
Subsequent Event [Line Items] | |||
Number of stock issued for consideration | 49,320 | ||
Percentage of shares transfered as consideration | 0.05% | ||
Subsequent Event [Member] | Dr. Low, Chan Kok Wei, Ong Bee Chen [Member] | Share Transfer Agreement With WKL Eco Earth Holdings [Member] | Allegro Investment BVI Limited [Member] | |||
Subsequent Event [Line Items] | |||
Number of stock issued for consideration | 8,280 | ||
Percentage of shares transfered as consideration | 0.009% | ||
Subsequent Event [Member] | Dr. Low, Chan Kok Wei, Ong Bee Chen [Member] | Share Transfer Agreement With WKL Eco Earth Holdings [Member] | WKLEE Sellers [Member] | |||
Subsequent Event [Line Items] | |||
Number of stock issued for consideration | 14,400 | ||
Percentage of shares transfered as consideration | 0.014% | ||
Subsequent Event [Member] | Tan Soon Hock [Member] | Investment Exchange Agreement With WKL Eco Earth Holdings [Member] | |||
Subsequent Event [Line Items] | |||
Number of stock issued for consideration | 7,037,762 | ||
Percentage of shares transfered as consideration | 6.91% | ||
Subsequent Event [Member] | Ivan Oh Joon Wern [Member] | Investment Exchange Agreement With WKL Eco Earth Holdings [Member] | |||
Subsequent Event [Line Items] | |||
Number of stock issued for consideration | 2,520,000 | ||
Percentage of shares transfered as consideration | 2.48% | ||
Subsequent Event [Member] | Relevant Interest Holders [Member] | Investment Exchange Agreement With WKL Eco Earth Holdings [Member] | |||
Subsequent Event [Line Items] | |||
Number of stock issued for consideration | 6,001,794 | ||
Percentage of shares transfered as consideration | 5.90% | ||
Subsequent Event [Member] | Dr. Low [Member] | Intellectual Properties Assignments With WKL Eco Earth Holdings [Member] | WKL Global Limited [Member] | |||
Subsequent Event [Line Items] | |||
Number of stock issued for consideration | 14,297,259 | ||
Percentage of shares transfered as consideration | 14.05% | ||
Subsequent Event [Member] | Dr. Low [Member] | Intellectual Properties Assignments With WKL Eco Earth Holdings [Member] | Allegro Investment BVI Limited [Member] | |||
Subsequent Event [Line Items] | |||
Number of stock issued for consideration | 5,487,752 | ||
Percentage of shares transfered as consideration | 5.39% | ||
Subsequent Event [Member] | Dr. Low [Member] | Intellectual Properties Assignments With WKL Eco Earth Holdings [Member] | IP Assignments [Member] | |||
Subsequent Event [Line Items] | |||
Number of stock issued for consideration | 63,362,756 | ||
Percentage of shares transfered as consideration | 62.25% |